AQILION AB
556623-2095ActiveDeveloping innovative treatments for chronic inflammatory diseases via early-stage partnering.
Yleiskatsaus
- 5–9
- Työntekijät
- 2.5–5milj SEK
- Liikevaihto
- 2002
- Perustettu
Avainpäättäjät
Sarah Fredriksson
Chief Executive Officer
Carina Eldh
Senior Director of Finance and Business Administration
Martin Olovsson
Board member
Malin Hultqvist
Senior Director Biology Discovery
+10 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Aqilion is a Swedish biotech company dedicated to developing innovative new treatments for diseases stemming from chronic inflammation and dysfunctional immunological reactions, such as autoimmune disorders. Their core mission involves identifying promising scientific ideas based on solid biological...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Konsultverksamhet avseende företags organisation
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE556623209501
Päättäjät
14 yhteystietoa FunnelfeedrissäSarah Fredriksson
Chief Executive Officer
Carina Eldh
Senior Director of Finance and Business Administration
Martin Olovsson
Board member
Malin Hultqvist
Senior Director Biology Discovery
Gunilla Savring
Board member
Kristina Masson
Board member
Roland Andersson
Board member
Fredrik Lindgren
Vice President Chief Business Officer
Jan Törnell
Vice President Chief Medical Scientist
Bertil Lindmark
Chairman of the Board
René Egebro
Senior Director of CMC
Johan Lund
Vice President Chief Scientific Officer
Anneli Tinnerholm
Senior Director Clinical Operations
Anders Kronborg
Board member
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäTribune Therapeutics AB
1–4 työntekijätDeveloping novel medicines to halt fibrotic disease progression across organs.
Oxion Biologics AB
3 työntekijätRevolutionizing treatment for immune-mediated diseases with novel therapy.
Transient Pharma AB
0 työntekijätDeveloping peptide drugs targeting severe inflammatory diseases using natural templates.
GLYCOREX TRANSPLANTATION AB (PUBL)
10–19 työntekijätDevelops technology to remove blood antibodies for transplants and disease.
Active Biotech AB (publ)
1–4 työntekijätDeveloping novel treatments for cancer and inflammatory eye diseases.
Selaa lisää
Kysymyksiä yrityksestä AQILION AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo